Notice of Special Interest (NOSI): Discovery and Development of Oral Small-molecule Direct-acting Antivirals Targeting Viruses of Pandemic Potential
This grant opportunity focuses on discovering and developing oral antiviral drugs targeting viruses with pandemic potential. The aim is to create a strong selection of drug candidates to be ready for future outbreaks and pandemics.
Source
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
Administration For Strategic Preparedness And Response
-
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
National Institutes of Health ▸ National Institute of Diabetes and Digestive and Kidney Diseases
-
Applied Learning Experiences Related to Drug Control Policy
Office of National Drug Control Policy
-
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
National Institutes of Health ▸ National Institute on Drug Abuse
-
Applied Drug Policy Research Experiences
Office of National Drug Control Policy
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers